News Americas, NEW YORK, NY, Thurs. Mar. 8, 2018: The world’s first lung cancer vaccine treatment from Cuba is now being used in several other Latin American countries and is the first Cuban patented drug to be allowed to undergo clinical trials at a U.S. cancer research institute.

CimaVax-EGF is a Cuban developed vaccine aimed at preventing the recurrence of the disease. Early results were so positive that in 2016, the Roswell Park Cancer Institute in the United States persuaded the U.S. government to allow it to test the vaccine.

Contrary to other lung cancer fighting drugs on the market, CimaVax does not work on attacking the cancer cells but instead it helps the body generate its own immune system in a way that starves the cancer and stops it from growing.

“It has revolutionized lung cancer treatment in our country. It’s a new therapeutic weapon for treating and maintaining the disease. Patients are responding well and surviving for longer than those not being treated with it,” said Oncologist Yoanna Flores.

Patients still have to complete a course of chemo or radio therapy before being eligible to receive the vaccines.

Caridad Gomez was diagnosed with lung cancer four years ago. After undergoing intensive chemotherapy, she is now under the lung cancer vaccine treatment.

“I feel good, I have even gained some weight. I’ve been using the vaccine for two years and four months now and so far I’ve felt really good,” said Gomez.

The vaccine is just one of an impressive array of cancer drugs developed at Cuba’s Center for Molecular Immunology.

The research center has been working on cancer treatments for more than 20 years. It already has drugs to help with pancreatic cancer and brain tumors. Lung cancer is its first vaccine. Now it’s working on one for prostate cancer.

It was Cuba’s former leader Fidel Castro who decided to concentrate on developing a world class biotechnology sector and it’s been well-funded ever since.

If the clinical trials now underway in the United States are successful, pharmaceuticals could prove to be a vital new income source for the Cuban economy. (SOURCE: CCTV)

Previous articleGuyanese Immigrant Wanted For Murder Sent Packing By ICE
Next articleThis Caribbean Player Is Now Part Of D.C. United
News Americas Now is is the only Black, woman-owned daily news platform in the U.S. dedicated to Caribbean diaspora and Black immigrant stories. We spotlight the people, policies, and culture shaping immigrant life — where Black immigrant voices lead the conversation and define the narrative. Where You Can Find Us 📌 Syndicated across 21+ platforms PLUS: ✅ Google News, Apple News, SyniGate Media, Newstex, Substack, Tempo TV, OURTV, Caribbean Today in Florida. ✅ Social Media: Facebook, Twitter (X), Instagram, YouTube, Pinterest, & LinkedIn What We Cover 🌍 Black Immigrant & U.S. Immigration News Essential coverage of U.S. immigration policy, Black immigrant issues, and diaspora voices shaping America. 📈 Caribbean Diaspora & Latin American Business Insights on business trends, diaspora entrepreneurship, trade, and Caribbean economic development. 🗞️ Caribbean Diaspora News & Breaking Headlines Daily news from across the Caribbean and Latin America that matters to the global diaspora. 🎭 Entertainment, Culture, Travel & Caribbean Politics Stories at the intersection of Caribbean culture, music, lifestyle, politics, and diaspora identity. 🌿 Marijuana News & Policy in the Caribbean Cannabis legalization, medicinal marijuana, and industry updates across the Caribbean and diaspora. Ranked & Recognized 🔹 Quoted by BBC, The Guardian UK, & NY Daily News 🔹 Named among Top 35 Blogs in Latin America 🔹 FeedSpot Top 45 Latin America Blogs 🔹 Listed as one of the Top 35 Caribbean News Websites on the Web OUR FOUNDER 🗣️ Felicia J. Persaud, CEO of ICN LLC which owns Invest Caribbean, Hard Beat Communications and CaribPR Wire, the PR Newswire of the Caribbean and partner of CISION PR NEWSWIRE. SUBMIT A HARD NEW STORY OR FEATURE THAT MEETS OUR NEWS GUIDLINES Black immigrant News Reporters and Caribbean and LATAM Expert Opinion Leaders are urged to submit their independent breaking news articles and opinions for publication to [email protected]. PUBLISHER/EDITOR-IN-CHIEF: Felicia J. Persaud EDITOR: Dave Frankel PARTNER WITH US For partnership options connect today. Follow. Subscribe. Share. Stay informed. Stay empowered.